BIO Applauds House Passage of the Fostering Innovation Act

BIO applauds the US House of Representatives for passing H.R. 4139, the Fostering Innovation Act.  The bipartisan legislation was introduced by Reps. Kyrsten Sinema (D-AZ) and Michael Fitzpatrick (R-PA).

Arizona Governor Ducey Signs Bill Ensuring Patient Access to Interchangeable Biologic Medicines

The Biotechnology Innovation Organization (BIO) and Arizona BioIndustry Association (AZBio) commend Governor Doug Ducey for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines.

BIO Disappointed in Approps Action to Label GE Salmon

Senate Ag Committee Efforts Will Better Address Transparency Washington, D.C. (May 19, 2016) – During markup of the FY17 Agriculture Appropriations Bill, the Senate Appropriations Committee approved today by voice vote an amendment to mandate the identification of genetically engineered salmon as “genetically engineered” or “GE” in the marketplace. 

BIO Letter to Senate Appropriations Leadership on Efforts to Label Foods Produced Through Biotechnology Such As the Genetically Engineered Salmon

The Biotechnology Innovation Organization (BIO) urges you and all members of the Senate Appropriations Committee to support a national bioengineered food labeling legislative solution, which Senators Pat Roberts (R-KS) and Debbie Stabenow (D-MI) are currently crafting in the Senate Agriculture Committee, and to reject all efforts to establish unique labeling requirements for specific bioengineered food products, such as salmon, during consideration of the Fiscal Year 2017 spending bills.

BIO Releases Investment and Deal Making Study Showing Record-Breaking Year for US Venture Capital Funding of Biotech

Today, the Biotechnology Innovation Organization (BIO) released a new report - Emerging Therapeutic Company Investment and Deal Trends – highlighting ten years (2006-2015) of biotechnology funding and deal making across five areas: venture capital, IPOs, follow-on public offerings, licensing, and acquisitions. 

Top Political Experts to Discuss Presidential Election at 2016 BIO International Convention

The Honorable Newt Gingrich, Candy Crowley and Stephanie Cutter to participate on keynote panel Wednesday, June 8. A former Speaker of the House, an award winning journalist and a top political strategist will lead a spirited discussion on the 2016 presidential election and its potential impact on the biotechnology industry and the global economy at the 2016 Biotechnology Innovation Organization (BIO) Convention.

BIO Statement on EPA’s Proposed Rule for the 2017 Renewable Fuel Standards

The proposed rule for the 2017 Renewable Fuel Standard (RFS), issued today by the Environmental Protection Agency (EPA), fails to put the program fully back on track and continues to create uncertainty for advanced and cellulosic biofuel producers and their investors.

BIO Submits Comments to FDA's Draft EA and Preliminary FONSI Regarding the Proposed Field Trial of the OX513A Strain of Aedes aegypti (Ae. aegypti)

The Biotechnology Innovation Organization (BIO) appreciates this opportunity to provide comments to the U.S. Food and Drug Administration (FDA) on the draft environmental assessment (EA)1 and preliminary finding of no significant impact (FONSI) regarding the proposed field trial of the OX513A strain of Aedes aegypti (Ae. aegypti) developed by Oxitec.

NAS Report Upholds Safety of GE Crops and Foods

There’s no evidence to suggest that foods from genetically engineered (GE) crops are less safe than foods from non-GE crops, according to a new National Academies of Sciences report.

BIO Comments Re: Comments on Sharing Clinical Trial Data: A Proposal From the International Committee of Medical Journal Editors

Dear Dr. Taichman: